Analysis Overview:
Novartis AG has shown a strong recovery, bouncing back from its recent low near $91.84, a key support level that held well. The stock is now trading at $103.29 (+3.32%), approaching its mid-term moving averages, signaling renewed momentum.
Key Levels:
Support: $91.84 (Strong base where buyers stepped in).
Resistance: $120.88 (Previous swing high).
Indicators and Patterns:
The price has crossed above the short-term moving average, indicating early bullish momentum.
Volume is picking up, supporting the price recovery.
Breakout above $120.88 would confirm further upside potential.
Trading Idea:
Bullish: Entry on pullbacks near $100, with a target of $120.88 and a stop-loss below $91.
Bearish: Watch for rejection near $120.88 for a potential short opportunity, targeting $100.
Disclaimer:
This analysis is for educational purposes and is not financial advice. Always perform your own research before making trading decisions.
Novartis AG has shown a strong recovery, bouncing back from its recent low near $91.84, a key support level that held well. The stock is now trading at $103.29 (+3.32%), approaching its mid-term moving averages, signaling renewed momentum.
Key Levels:
Support: $91.84 (Strong base where buyers stepped in).
Resistance: $120.88 (Previous swing high).
Indicators and Patterns:
The price has crossed above the short-term moving average, indicating early bullish momentum.
Volume is picking up, supporting the price recovery.
Breakout above $120.88 would confirm further upside potential.
Trading Idea:
Bullish: Entry on pullbacks near $100, with a target of $120.88 and a stop-loss below $91.
Bearish: Watch for rejection near $120.88 for a potential short opportunity, targeting $100.
Disclaimer:
This analysis is for educational purposes and is not financial advice. Always perform your own research before making trading decisions.
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.